Vernalis, a specialty bio-pharmaceutical company, has appointed Ian Garland as its new CEO and David Mackney as its new CFO. Mr Garland is expected to take up his position with the company in December 2008 and Mr Mackney will join the company on February 1, 2009.
From May 2007 until September 2008, Mr Garland was CEO of Acambis, a company engaged in the development of novel vaccines.
No comments:
Post a Comment